(Q36722379)

15 August 2017

Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate (English)

1 reference

15 August 2017

1 reference

Tan TT

1

1 reference

15 August 2017

Alzaid AA

2

1 reference

15 August 2017

Sutcliffe N

3

1 reference

15 August 2017

Gardner MD

4

1 reference

15 August 2017

Thomson JA

5

1 reference

15 August 2017

Boyle IT

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 1988

1 reference

Postgraduate Medical Journal

15 August 2017

1 reference

15 August 2017

64

1 reference

15 August 2017

749

1 reference

15 August 2017

224-227

1 reference

The effect of thyroid disease on calcium metabolism in man

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428854

Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428854

Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428854

Control of hypercalcaemia in thyrotoxicosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428854

Direct stimulation of bone resorption by thyroid hormones

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428854

Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428854

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428854

Treatment of Thyrotoxic Hypercalcemia with Propranolol

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428854

Investigation of bone and mineral metabolism in hyperthyroidism before and after treatment using calcitonin, 47Ca and balance studies

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428854

Predictive value of derived calcium figures based on the measurement of ionised calcium.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2428854

Symptomatic Hypercalcaemia in Thyrotoxicosis

5 September 2018

1 reference

12 December 2020

Thyrotoxic hypercalcaemia treated with porcine calcitonin

1 reference

12 December 2020

Hypercalcemia of thyrotoxicosis

1 reference

12 December 2020

Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia

1 reference

12 December 2020

Identifiers

DOI

10.1136/PGMJ.64.749.224

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

3174541

1 reference